Concepts (269)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Critical Care | 20 | 2022 | 684 | 4.240 |
Why?
|
| Heart Defects, Congenital | 26 | 2022 | 1874 | 3.360 |
Why?
|
| Cardiopulmonary Bypass | 14 | 2021 | 359 | 3.150 |
Why?
|
| Cardiac Surgical Procedures | 17 | 2024 | 1156 | 2.270 |
Why?
|
| Pediatrics | 12 | 2022 | 1243 | 2.130 |
Why?
|
| Hemodynamics | 14 | 2023 | 805 | 2.010 |
Why?
|
| Critical Illness | 11 | 2023 | 621 | 2.010 |
Why?
|
| Monitoring, Physiologic | 11 | 2022 | 369 | 1.690 |
Why?
|
| Oxygen | 8 | 2021 | 553 | 1.570 |
Why?
|
| Intensive Care Units, Pediatric | 9 | 2021 | 493 | 1.440 |
Why?
|
| Shock, Cardiogenic | 2 | 2023 | 172 | 1.430 |
Why?
|
| Cardiology | 4 | 2017 | 513 | 1.400 |
Why?
|
| Oximetry | 7 | 2021 | 176 | 1.300 |
Why?
|
| Spectroscopy, Near-Infrared | 4 | 2021 | 157 | 1.270 |
Why?
|
| Heart Failure | 8 | 2016 | 2322 | 1.260 |
Why?
|
| Cardiovascular System | 2 | 2023 | 97 | 1.180 |
Why?
|
| Capnography | 2 | 2020 | 13 | 1.180 |
Why?
|
| Sepsis | 2 | 2023 | 494 | 1.130 |
Why?
|
| Heart Diseases | 4 | 2019 | 501 | 1.130 |
Why?
|
| Nitric Oxide | 5 | 2019 | 465 | 0.940 |
Why?
|
| Child | 46 | 2022 | 26097 | 0.930 |
Why?
|
| Natriuretic Peptide, Brain | 3 | 2017 | 324 | 0.870 |
Why?
|
| Cardiac Output | 7 | 2022 | 152 | 0.860 |
Why?
|
| Physicians | 3 | 2022 | 634 | 0.840 |
Why?
|
| Humans | 84 | 2024 | 130342 | 0.820 |
Why?
|
| Arginine Vasopressin | 1 | 2023 | 25 | 0.810 |
Why?
|
| Heart | 4 | 2023 | 659 | 0.790 |
Why?
|
| Blood Pressure | 6 | 2022 | 1344 | 0.730 |
Why?
|
| Extracorporeal Membrane Oxygenation | 6 | 2014 | 675 | 0.730 |
Why?
|
| Hypertension, Pulmonary | 5 | 2019 | 450 | 0.720 |
Why?
|
| Certification | 2 | 2019 | 68 | 0.710 |
Why?
|
| Cerebrovascular Circulation | 3 | 2021 | 484 | 0.690 |
Why?
|
| Tetralogy of Fallot | 3 | 2012 | 169 | 0.690 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2021 | 161 | 0.680 |
Why?
|
| Fontan Procedure | 1 | 2023 | 180 | 0.680 |
Why?
|
| Inflammation | 2 | 2020 | 1483 | 0.680 |
Why?
|
| Lung | 2 | 2020 | 1535 | 0.670 |
Why?
|
| Postoperative Complications | 8 | 2020 | 3120 | 0.670 |
Why?
|
| Heart-Assist Devices | 3 | 2022 | 1013 | 0.650 |
Why?
|
| Natriuretic Agents | 2 | 2017 | 28 | 0.640 |
Why?
|
| Acute Kidney Injury | 3 | 2017 | 695 | 0.630 |
Why?
|
| Infant, Newborn | 17 | 2022 | 8532 | 0.630 |
Why?
|
| Infant | 24 | 2020 | 13239 | 0.590 |
Why?
|
| Triiodothyronine | 1 | 2019 | 54 | 0.590 |
Why?
|
| Internationality | 1 | 2019 | 128 | 0.580 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 333 | 0.560 |
Why?
|
| Education, Medical, Graduate | 2 | 2022 | 552 | 0.560 |
Why?
|
| Hypothyroidism | 1 | 2019 | 76 | 0.560 |
Why?
|
| Postoperative Care | 5 | 2020 | 294 | 0.550 |
Why?
|
| Respiratory Tract Diseases | 2 | 2016 | 81 | 0.550 |
Why?
|
| Curriculum | 2 | 2022 | 787 | 0.540 |
Why?
|
| Hospital Mortality | 5 | 2021 | 1059 | 0.530 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 3031 | 0.510 |
Why?
|
| Vasopressins | 3 | 2021 | 42 | 0.500 |
Why?
|
| Carbon Dioxide | 2 | 2020 | 273 | 0.500 |
Why?
|
| Hormone Replacement Therapy | 1 | 2019 | 187 | 0.490 |
Why?
|
| Immunomodulation | 1 | 2016 | 84 | 0.470 |
Why?
|
| Respiratory System | 1 | 2016 | 96 | 0.470 |
Why?
|
| Reperfusion Injury | 1 | 2016 | 110 | 0.460 |
Why?
|
| Shock | 1 | 2016 | 97 | 0.450 |
Why?
|
| Societies, Medical | 5 | 2015 | 799 | 0.440 |
Why?
|
| Clinical Competence | 2 | 2019 | 1063 | 0.440 |
Why?
|
| Immune System Diseases | 1 | 2015 | 55 | 0.440 |
Why?
|
| Child, Preschool | 18 | 2020 | 14949 | 0.430 |
Why?
|
| Congresses as Topic | 1 | 2015 | 184 | 0.420 |
Why?
|
| Child Abuse | 1 | 2017 | 223 | 0.410 |
Why?
|
| Education, Medical | 1 | 2017 | 293 | 0.400 |
Why?
|
| Shock, Septic | 1 | 2015 | 148 | 0.400 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2013 | 41 | 0.400 |
Why?
|
| Ventilator Weaning | 2 | 2010 | 30 | 0.390 |
Why?
|
| Fellowships and Scholarships | 1 | 2016 | 323 | 0.390 |
Why?
|
| Oxygen Consumption | 2 | 2011 | 299 | 0.380 |
Why?
|
| Vascular Resistance | 2 | 2020 | 182 | 0.380 |
Why?
|
| Cardiovascular Diseases | 3 | 2016 | 2099 | 0.380 |
Why?
|
| Vancomycin | 1 | 2014 | 221 | 0.370 |
Why?
|
| Regional Blood Flow | 1 | 2012 | 191 | 0.360 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2011 | 16 | 0.350 |
Why?
|
| Airway Extubation | 1 | 2012 | 70 | 0.350 |
Why?
|
| Length of Stay | 6 | 2021 | 1398 | 0.340 |
Why?
|
| Positive-Pressure Respiration | 1 | 2010 | 84 | 0.320 |
Why?
|
| Cardiac Output, Low | 1 | 2010 | 59 | 0.320 |
Why?
|
| Interdisciplinary Communication | 1 | 2011 | 130 | 0.320 |
Why?
|
| Intensive Care Units | 6 | 2020 | 525 | 0.310 |
Why?
|
| Pituitary-Adrenal System | 1 | 2010 | 33 | 0.310 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2010 | 57 | 0.310 |
Why?
|
| Adrenal Insufficiency | 1 | 2010 | 30 | 0.300 |
Why?
|
| Brain | 2 | 2012 | 3168 | 0.300 |
Why?
|
| Treatment Outcome | 12 | 2024 | 12840 | 0.300 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2010 | 78 | 0.300 |
Why?
|
| Retrospective Studies | 15 | 2022 | 17516 | 0.290 |
Why?
|
| Coronary Care Units | 4 | 2020 | 34 | 0.290 |
Why?
|
| Evidence-Based Medicine | 2 | 2016 | 644 | 0.280 |
Why?
|
| Diuretics | 3 | 2019 | 157 | 0.280 |
Why?
|
| Postoperative Period | 4 | 2019 | 331 | 0.280 |
Why?
|
| Respiration, Artificial | 6 | 2019 | 505 | 0.280 |
Why?
|
| Steroids | 1 | 2009 | 169 | 0.270 |
Why?
|
| Infusions, Intravenous | 3 | 2020 | 535 | 0.270 |
Why?
|
| Peritoneal Dialysis | 2 | 2020 | 132 | 0.270 |
Why?
|
| Arteries | 2 | 2019 | 209 | 0.250 |
Why?
|
| Fluid Therapy | 2 | 2022 | 146 | 0.250 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2020 | 1271 | 0.240 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2021 | 128 | 0.240 |
Why?
|
| Hospitalization | 5 | 2021 | 1928 | 0.240 |
Why?
|
| Dexamethasone | 3 | 2005 | 250 | 0.240 |
Why?
|
| Anti-Inflammatory Agents | 4 | 2024 | 299 | 0.230 |
Why?
|
| Administration, Inhalation | 3 | 2019 | 191 | 0.230 |
Why?
|
| Prospective Studies | 7 | 2020 | 6438 | 0.220 |
Why?
|
| Respiration | 3 | 2016 | 119 | 0.220 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2009 | 323 | 0.220 |
Why?
|
| Male | 22 | 2020 | 64409 | 0.210 |
Why?
|
| Creatinine | 2 | 2017 | 396 | 0.210 |
Why?
|
| Acute Disease | 3 | 2016 | 1145 | 0.200 |
Why?
|
| Mediastinum | 1 | 2023 | 44 | 0.200 |
Why?
|
| Cause of Death | 2 | 2019 | 502 | 0.200 |
Why?
|
| Heart Rate | 3 | 2020 | 575 | 0.200 |
Why?
|
| Female | 22 | 2020 | 70331 | 0.200 |
Why?
|
| Time Factors | 6 | 2019 | 6197 | 0.200 |
Why?
|
| Hemodynamic Monitoring | 1 | 2022 | 16 | 0.190 |
Why?
|
| Water | 1 | 2023 | 185 | 0.190 |
Why?
|
| Cooperative Behavior | 2 | 2016 | 222 | 0.190 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 2562 | 0.180 |
Why?
|
| Vena Cava, Superior | 1 | 2021 | 58 | 0.170 |
Why?
|
| Case-Control Studies | 3 | 2019 | 3362 | 0.170 |
Why?
|
| Biological Transport | 2 | 2011 | 329 | 0.160 |
Why?
|
| Age Factors | 2 | 2019 | 2828 | 0.160 |
Why?
|
| Tidal Volume | 1 | 2020 | 42 | 0.160 |
Why?
|
| Nicardipine | 1 | 2020 | 15 | 0.160 |
Why?
|
| Nitroprusside | 1 | 2020 | 35 | 0.160 |
Why?
|
| Sodium Bicarbonate | 1 | 2020 | 55 | 0.160 |
Why?
|
| United States | 6 | 2022 | 11859 | 0.160 |
Why?
|
| Hypotension | 1 | 2021 | 183 | 0.150 |
Why?
|
| Vasoconstrictor Agents | 1 | 2020 | 137 | 0.150 |
Why?
|
| Risk Assessment | 5 | 2021 | 3672 | 0.150 |
Why?
|
| Cardiomyopathies | 2 | 2020 | 517 | 0.150 |
Why?
|
| Heart Septal Defects | 1 | 2019 | 42 | 0.150 |
Why?
|
| Acidosis | 1 | 2020 | 97 | 0.150 |
Why?
|
| Noonan Syndrome | 1 | 2019 | 31 | 0.150 |
Why?
|
| Arginine | 1 | 2021 | 337 | 0.140 |
Why?
|
| Bronchodilator Agents | 1 | 2019 | 156 | 0.140 |
Why?
|
| Heart Valve Diseases | 1 | 2019 | 165 | 0.130 |
Why?
|
| Respiratory Insufficiency | 2 | 2012 | 241 | 0.130 |
Why?
|
| Oliguria | 1 | 2017 | 20 | 0.130 |
Why?
|
| Water-Electrolyte Balance | 1 | 2017 | 81 | 0.130 |
Why?
|
| Recovery of Function | 1 | 2019 | 444 | 0.130 |
Why?
|
| Chlorothiazide | 1 | 2016 | 11 | 0.130 |
Why?
|
| Nephrons | 1 | 2016 | 17 | 0.130 |
Why?
|
| Diuresis | 1 | 2016 | 44 | 0.130 |
Why?
|
| Nurses | 1 | 2017 | 73 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 1611 | 0.120 |
Why?
|
| Veins | 1 | 2017 | 95 | 0.120 |
Why?
|
| Reoperation | 1 | 2019 | 818 | 0.120 |
Why?
|
| Adolescent | 6 | 2021 | 20718 | 0.120 |
Why?
|
| Equipment and Supplies, Hospital | 1 | 2015 | 10 | 0.120 |
Why?
|
| Ventricular Pressure | 1 | 2016 | 36 | 0.120 |
Why?
|
| Alprostadil | 1 | 2015 | 20 | 0.120 |
Why?
|
| Specialization | 1 | 2016 | 75 | 0.120 |
Why?
|
| Risk Factors | 4 | 2020 | 10941 | 0.120 |
Why?
|
| Inpatients | 1 | 2020 | 558 | 0.110 |
Why?
|
| Survival Analysis | 3 | 2019 | 1481 | 0.110 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 726 | 0.110 |
Why?
|
| Weight Gain | 1 | 2017 | 382 | 0.110 |
Why?
|
| Educational Measurement | 1 | 2017 | 316 | 0.110 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2016 | 134 | 0.110 |
Why?
|
| Heart Ventricles | 1 | 2019 | 758 | 0.110 |
Why?
|
| Premedication | 2 | 2005 | 39 | 0.110 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 1374 | 0.110 |
Why?
|
| Follow-Up Studies | 3 | 2020 | 5162 | 0.100 |
Why?
|
| Vasodilator Agents | 1 | 2015 | 198 | 0.100 |
Why?
|
| Single-Blind Method | 1 | 2014 | 236 | 0.100 |
Why?
|
| Cardiotonic Agents | 2 | 2014 | 139 | 0.100 |
Why?
|
| Pregnancy Complications | 2 | 2017 | 540 | 0.100 |
Why?
|
| Publications | 1 | 2013 | 36 | 0.100 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 564 | 0.100 |
Why?
|
| Global Health | 1 | 2017 | 633 | 0.090 |
Why?
|
| Databases, Factual | 3 | 2020 | 1223 | 0.090 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2014 | 217 | 0.090 |
Why?
|
| Thrombolytic Therapy | 1 | 2014 | 197 | 0.090 |
Why?
|
| Fibrinolytic Agents | 1 | 2014 | 190 | 0.090 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 1216 | 0.090 |
Why?
|
| Endothelium-Dependent Relaxing Factors | 1 | 2012 | 5 | 0.090 |
Why?
|
| Logistic Models | 2 | 2014 | 1799 | 0.090 |
Why?
|
| Patient Care Team | 1 | 2016 | 558 | 0.090 |
Why?
|
| Animals | 4 | 2024 | 33796 | 0.090 |
Why?
|
| Lung Diseases | 1 | 2016 | 396 | 0.090 |
Why?
|
| Texas | 3 | 2015 | 3643 | 0.090 |
Why?
|
| Pulmonary Embolism | 1 | 2014 | 191 | 0.090 |
Why?
|
| Hypertension | 1 | 2020 | 1347 | 0.090 |
Why?
|
| Quality Control | 1 | 2011 | 115 | 0.090 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2014 | 263 | 0.090 |
Why?
|
| Chronic Disease | 1 | 2016 | 1236 | 0.090 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 3795 | 0.080 |
Why?
|
| Calcium | 1 | 2016 | 1022 | 0.080 |
Why?
|
| California | 1 | 2010 | 126 | 0.080 |
Why?
|
| Kidney | 1 | 2017 | 1277 | 0.080 |
Why?
|
| Respiratory Mechanics | 1 | 2010 | 80 | 0.080 |
Why?
|
| Cardiovascular Agents | 1 | 2010 | 88 | 0.080 |
Why?
|
| Registries | 2 | 2019 | 1609 | 0.080 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2009 | 28 | 0.070 |
Why?
|
| Hospitals, Pediatric | 1 | 2014 | 798 | 0.070 |
Why?
|
| Reperfusion | 1 | 2009 | 26 | 0.070 |
Why?
|
| Pressure | 1 | 2009 | 121 | 0.070 |
Why?
|
| Hematologic Diseases | 1 | 2008 | 82 | 0.070 |
Why?
|
| Biomarkers | 2 | 2014 | 3382 | 0.070 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2009 | 208 | 0.060 |
Why?
|
| Quality Assurance, Health Care | 1 | 2008 | 205 | 0.060 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2010 | 363 | 0.060 |
Why?
|
| Incidence | 1 | 2014 | 3316 | 0.060 |
Why?
|
| Obesity | 1 | 2017 | 2381 | 0.060 |
Why?
|
| Methylprednisolone | 1 | 2005 | 94 | 0.060 |
Why?
|
| Linear Models | 2 | 2017 | 686 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 1288 | 0.050 |
Why?
|
| Cannabinoids | 1 | 2024 | 32 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 1445 | 0.050 |
Why?
|
| Glucocorticoids | 1 | 2005 | 346 | 0.050 |
Why?
|
| Cytokines | 1 | 2009 | 1343 | 0.050 |
Why?
|
| Central Venous Pressure | 1 | 2022 | 25 | 0.050 |
Why?
|
| Troponin I | 1 | 2003 | 122 | 0.050 |
Why?
|
| Phentolamine | 1 | 2021 | 15 | 0.040 |
Why?
|
| Calcium Chloride | 1 | 2021 | 23 | 0.040 |
Why?
|
| Prognosis | 1 | 2011 | 4859 | 0.040 |
Why?
|
| Morbidity | 2 | 2015 | 257 | 0.040 |
Why?
|
| Japan | 1 | 2020 | 161 | 0.040 |
Why?
|
| Complement C3a | 1 | 2000 | 18 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2003 | 1622 | 0.040 |
Why?
|
| Lactic Acid | 1 | 2020 | 148 | 0.040 |
Why?
|
| Medical Staff, Hospital | 1 | 2020 | 94 | 0.040 |
Why?
|
| Body Temperature | 1 | 2000 | 126 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2000 | 247 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2020 | 410 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 214 | 0.040 |
Why?
|
| Arterial Pressure | 1 | 2020 | 131 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2000 | 410 | 0.030 |
Why?
|
| Neutrophils | 1 | 2000 | 361 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2000 | 636 | 0.030 |
Why?
|
| Risk Adjustment | 1 | 2017 | 55 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2020 | 533 | 0.030 |
Why?
|
| Furosemide | 1 | 2016 | 36 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2016 | 236 | 0.030 |
Why?
|
| Down Syndrome | 1 | 2019 | 234 | 0.030 |
Why?
|
| Pulmonary Artery | 1 | 2020 | 437 | 0.030 |
Why?
|
| Birthing Centers | 1 | 2015 | 9 | 0.030 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2017 | 227 | 0.030 |
Why?
|
| Bradycardia | 1 | 2014 | 57 | 0.030 |
Why?
|
| Pregnancy | 2 | 2017 | 7418 | 0.020 |
Why?
|
| Advanced Cardiac Life Support | 1 | 2013 | 18 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 1166 | 0.020 |
Why?
|
| Gases | 1 | 2012 | 18 | 0.020 |
Why?
|
| Tertiary Care Centers | 1 | 2014 | 248 | 0.020 |
Why?
|
| Missouri | 1 | 2012 | 43 | 0.020 |
Why?
|
| Catheterization | 1 | 2014 | 223 | 0.020 |
Why?
|
| Hypoglycemia | 1 | 2014 | 183 | 0.020 |
Why?
|
| Troponin | 1 | 2012 | 69 | 0.020 |
Why?
|
| Adult | 3 | 2020 | 31121 | 0.020 |
Why?
|
| Radiography | 1 | 2014 | 743 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2014 | 708 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2017 | 1675 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2014 | 433 | 0.020 |
Why?
|
| Recurrence | 1 | 2014 | 1470 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2014 | 955 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2014 | 602 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2012 | 1449 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 2193 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2005 | 277 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 9988 | 0.010 |
Why?
|
| Perioperative Care | 1 | 2005 | 221 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 425 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 20859 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2003 | 936 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 28366 | 0.010 |
Why?
|